Editorial
Nature Biotechnology 25, 1061 (2007)
doi:10.1038/nbt1007-1061
Roadmap for revitalization?
Abstract
The newly passed US Food and Drug Administration's (FDA) Amendments Act (FDAAA) sets the stage for key improvements to postmarketing surveillance as well as the preapproval process.
